<record>
  <datafield tag="024" ind1="7" ind2=" ">
    <subfield code="a">10.1016/j.apradiso.2016.09.023</subfield>
    <subfield code="2">DOI</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">El-Kawy, O.A.</subfield>
    <subfield code="v">Labelled Compounds Department, Atomic Energy Authority, Cairo, 13759, Egypt</subfield>
    <subfield code="v">Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), FI-00014, Finland</subfield>
    <subfield code="m">elkawyo@gmail.com</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Labelling, molecular modelling and biological evaluation of vardenafil: a potential agent for diagnostic evaluation of erectile dysfunction</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2016-12</subfield>
    <subfield code="t">published</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="a">8</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">99m Tc–tricarbonyl–vardenafil was specifically radiosynthesized for diagnostic evaluation of erectile dysfunction with a radiochemical yield ~97.2%. It was stable in saline up to 15 h and in serum for more than 6 h. The radiocomplex was lipophilic with a partition coefficient ~1.32 and plasma protein binding 72–76%. Its structure was determined using molecular mechanics and confirmed by NMR. In-silico docking to its target PDE 5 enzyme was performed. The radiocomplex inhibitory activity was assessed and its IC 50 was 0.7 nM. Biodistribution in normal rats and biological evaluation in rat models of erectile dysfunction were performed. The results strongly suggested that 99m Tc–tricarbonyl–vardenafil is a good candidate to image erectile dysfunction in humans.</subfield>
    <subfield code="9">Elsevier</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="f">Elsevier Ltd</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Erectile dysfunction</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Labelling</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Vardenafil</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Technetium-99m</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Tracer</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="653" ind1="1" ind2=" ">
    <subfield code="a">Biological evaluation</subfield>
    <subfield code="9">author</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">García-Horsman, J.A.</subfield>
    <subfield code="v">Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), FI-00014, Finland</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="a">Tuominen, R.K.</subfield>
    <subfield code="v">Faculty of Pharmacy, Division of Pharmacology and Pharmacotherapy, University of Helsinki, P.O. Box 56 (Viikinkaari 5E), FI-00014, Finland</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="p">Appl.Radiat.Isot.</subfield>
    <subfield code="c">258-265</subfield>
    <subfield code="v">118</subfield>
    <subfield code="y">2016</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">HEP</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Citeable</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">Published</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Andersson, K.</subfield>
    <subfield code="t">Mechanisms of penile erection and basis for pharmacological treatment of erectile dysfunction</subfield>
    <subfield code="v">63</subfield>
    <subfield code="y">2011</subfield>
    <subfield code="o">Andersson, 2011</subfield>
    <subfield code="s">Pharm.Rev.,63,811</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Kubin, M.</subfield>
    <subfield code="h">Wagner, G.</subfield>
    <subfield code="h">Fugl-Meyer, A.</subfield>
    <subfield code="t">Epidemiology of erectile dysfunction</subfield>
    <subfield code="v">15</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Kubin et al, 2003</subfield>
    <subfield code="s">Int.J.Impot.Res.,15,63</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Gajbhiye, S.</subfield>
    <subfield code="h">Jadhay, K.</subfield>
    <subfield code="h">Marathe, P.</subfield>
    <subfield code="h">Pawar, D.</subfield>
    <subfield code="t">Animal models of erectile dysfunction</subfield>
    <subfield code="v">31</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Gajbhiye et al, 2015</subfield>
    <subfield code="s">Ind.J.Urol.,31,15</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="a">10.1155/2010/730861</subfield>
    <subfield code="h">Lasker, G.</subfield>
    <subfield code="h">Maley, J.</subfield>
    <subfield code="h">Kadowitz, P.</subfield>
    <subfield code="t">A review of the pathophysiology and novel treatments for erectile dysfunction</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Lasker et al, 2010</subfield>
    <subfield code="s">Adv.Pharm.Sci.</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Andersson, K.</subfield>
    <subfield code="t">Pharmacology of penile erection</subfield>
    <subfield code="v">53</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">Andersson, 2001</subfield>
    <subfield code="s">Pharm.Rev.,53,417</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Craven, M.</subfield>
    <subfield code="h">Sergeant, G.</subfield>
    <subfield code="h">Hollywood, M.</subfield>
    <subfield code="h">McHale, N.</subfield>
    <subfield code="h">Thornbury, K.</subfield>
    <subfield code="t">Modulation of spontaneous Ca 2+ activated Cl - currents in the rabbit corpus cavernosum by the nitric oxide-cGMP pathway</subfield>
    <subfield code="v">556</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Craven et al, 2004</subfield>
    <subfield code="s">J.Physiol.,556,495</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Corbin, J.</subfield>
    <subfield code="t">Mechanisms of action of PDE5 inhibition in erectile dysfunction</subfield>
    <subfield code="v">16</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Corbin, 2004</subfield>
    <subfield code="s">Int.J.Impot.Res.,16,S4</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Aversa, A.</subfield>
    <subfield code="t">Systemic and metabolic effects of PDE5-inhibitor drugs</subfield>
    <subfield code="v">1</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Aversa, 2010</subfield>
    <subfield code="s">World J.Diabetes,1,3</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Morales, A.</subfield>
    <subfield code="h">Gingell, C.</subfield>
    <subfield code="h">Collins, M.</subfield>
    <subfield code="h">Wicker, P.</subfield>
    <subfield code="h">Osterloh, I.</subfield>
    <subfield code="t">Clinical safety of oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction</subfield>
    <subfield code="v">10</subfield>
    <subfield code="y">1998</subfield>
    <subfield code="o">Morales et al, 1998</subfield>
    <subfield code="s">Int J.Impot.Res.,10,69</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">El-Kawy, O.</subfield>
    <subfield code="h">Ibrahim, I.</subfield>
    <subfield code="h">Farah, K.</subfield>
    <subfield code="t">Technetium-99m labeling and evaluation of olsalazine: a novel agent for ulcerative colitis imaging</subfield>
    <subfield code="v">58</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">El-Kawy et al, 2015</subfield>
    <subfield code="s">J.Label.Compd.Radiopharm.,58,336</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">El-Kawy, O.</subfield>
    <subfield code="h">Talaat, H.</subfield>
    <subfield code="t">Preparation, characterization and evaluation of 186 Re-idarubicin: a novel agent for diagnosis and treatment of hepatocellular carcinoma</subfield>
    <subfield code="v">59</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">El-Kawy and Talaat, 2016</subfield>
    <subfield code="s">J.Label.Compd.Radiopharm.,59,72</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">El-kawy, O.</subfield>
    <subfield code="h">Abdel-Razek, A.</subfield>
    <subfield code="h">Sayed, M.</subfield>
    <subfield code="t">Radiolabeling, biological evaluation and molecular docking of delafloxacin: a novel methicillin-resistant Staphylococcus aureus infection radiotracer</subfield>
    <subfield code="v">308</subfield>
    <subfield code="y">2016</subfield>
    <subfield code="o">El-kawy et al, 2016</subfield>
    <subfield code="s">J.Radioanal.Nucl.Chem.,308,1081</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Card, G.</subfield>
    <subfield code="h">England, B.</subfield>
    <subfield code="h">Suzuki, Y.</subfield>
    <subfield code="h">Fong, D.</subfield>
    <subfield code="h">Powell, B.</subfield>
    <subfield code="h">Lee, B.</subfield>
    <subfield code="h">Luu, C.</subfield>
    <subfield code="h">Tabrizizad, M.</subfield>
    <subfield code="h">Gillette, S.</subfield>
    <subfield code="h">Ibrahim, P.</subfield>
    <subfield code="h">Artis, D.</subfield>
    <subfield code="h">Bollag, G.</subfield>
    <subfield code="h">Milburn, M.</subfield>
    <subfield code="h">Kim, S.</subfield>
    <subfield code="h">Schlessinger, J.</subfield>
    <subfield code="h">Zhang, K.</subfield>
    <subfield code="t">Structural basis for the activity of drugs that inhibit phosphodiesterases</subfield>
    <subfield code="v">12</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Card et al, 2004</subfield>
    <subfield code="s">Structure,12,2233</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">De, K.</subfield>
    <subfield code="h">Chandra, S.</subfield>
    <subfield code="h">Sarkar, B.</subfield>
    <subfield code="h">Ganguly, S.</subfield>
    <subfield code="h">Misra, M.</subfield>
    <subfield code="t">Synthesis and biological evaluation of 99m Tc-DHPM complex: a potential new radiopharmaceutical for lung imaging studies</subfield>
    <subfield code="v">283</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">De et al, 2010</subfield>
    <subfield code="s">J.Radioanal.Nucl.Chem.,283,621</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">El-Kawy, O.</subfield>
    <subfield code="h">Farah, K.</subfield>
    <subfield code="t">Radiocomplexation and biological evaluation of nemonoxacin in mice infected with multiresistant Staphylococcus aureus and penicillin-resistant Streptococci</subfield>
    <subfield code="v">306</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">El-Kawy and Farah, 2015</subfield>
    <subfield code="s">J.Radioanal.Nucl.Chem.,306,123</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Staeben, M.</subfield>
    <subfield code="h">Kleman-Leyer, K.</subfield>
    <subfield code="h">Kopp, A.</subfield>
    <subfield code="h">Westermeyer, T.</subfield>
    <subfield code="h">Lowery, R.</subfield>
    <subfield code="t">Development and validation of a transcreener assay for detection of AMP- and GMP-producing Eenzymes</subfield>
    <subfield code="v">8</subfield>
    <subfield code="y">2010</subfield>
    <subfield code="o">Staeben et al, 2010</subfield>
    <subfield code="s">Assay.Drug Dev.Technol.,8,344</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Gaibhive, S.</subfield>
    <subfield code="h">Jadhav, K.</subfield>
    <subfield code="h">Marathe, P.</subfield>
    <subfield code="h">Pawar, D.</subfield>
    <subfield code="t">Animal models of erectile dysfunction</subfield>
    <subfield code="v">31</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Gaibhive et al, 2015</subfield>
    <subfield code="s">Ind.J.Urol.,31,15</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Corbin, J.</subfield>
    <subfield code="h">Beasley, A.</subfield>
    <subfield code="h">Blount, M.</subfield>
    <subfield code="h">Francis, S.</subfield>
    <subfield code="t">Vardenafil: structural basis for higher potency over sildenafil in inhibiting cGMP-specific phosphodiesterase-5 (PDE5)</subfield>
    <subfield code="v">45</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Corbin et al, 2004</subfield>
    <subfield code="s">Neurochem Inter,45,859</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Bischoff, E.</subfield>
    <subfield code="t">Vardenafil preclinical trial data: potency, pharmacodynamics, pharmacokinetics, and adverse events</subfield>
    <subfield code="v">16</subfield>
    <subfield code="y">2004</subfield>
    <subfield code="o">Bischoff, 2004</subfield>
    <subfield code="s">Int.J.Impot.Res.,16,S34</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Sung, B.</subfield>
    <subfield code="h">Hwang, K.</subfield>
    <subfield code="h">Jeon, Y.</subfield>
    <subfield code="h">Lee, J.</subfield>
    <subfield code="h">Heo, Y.</subfield>
    <subfield code="h">Kim, J.</subfield>
    <subfield code="h">Moon, J.</subfield>
    <subfield code="h">Yoon, J.</subfield>
    <subfield code="h">Hyun, Y.</subfield>
    <subfield code="h">Kim, E.</subfield>
    <subfield code="t">Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules</subfield>
    <subfield code="v">425</subfield>
    <subfield code="y">2003</subfield>
    <subfield code="o">Sung et al, 2003</subfield>
    <subfield code="s">Nature,425,98</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Radwan, A.</subfield>
    <subfield code="t">Pharmacophore elucidation and molecular docking studies on phosphodiesterase-5 inhibitors</subfield>
    <subfield code="v">11</subfield>
    <subfield code="y">2015</subfield>
    <subfield code="o">Radwan, 2015</subfield>
    <subfield code="s">Bioinformatics,11,63</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Chen, G.</subfield>
    <subfield code="h">Wang, H.</subfield>
    <subfield code="h">Robinson, H.</subfield>
    <subfield code="h">Cai, J.</subfield>
    <subfield code="h">Wan, Y.</subfield>
    <subfield code="h">Hengming, K.</subfield>
    <subfield code="t">An insight into the pharmacophores of phosphodiesterase-5 inhibitors from synthetic and crystal structural studies</subfield>
    <subfield code="v">75</subfield>
    <subfield code="y">2008</subfield>
    <subfield code="o">Chen et al, 2008</subfield>
    <subfield code="s">Biochem.Pharm.,75,1717</subfield>
  </datafield>
  <datafield tag="999" ind1="C" ind2="5">
    <subfield code="h">Saenz de Tejada, I.</subfield>
    <subfield code="h">Angulo, J.</subfield>
    <subfield code="h">Cuevas, P.</subfield>
    <subfield code="h">Fernandez, A.</subfield>
    <subfield code="h">Moncada, I.</subfield>
    <subfield code="h">Allona, A.</subfield>
    <subfield code="h">Lledo, E.</subfield>
    <subfield code="h">Korschen, H.</subfield>
    <subfield code="h">Niewohner, U.</subfield>
    <subfield code="h">Haning, H.</subfield>
    <subfield code="h">Pages, E.</subfield>
    <subfield code="h">Bischoff, E.</subfield>
    <subfield code="t">The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE 5 inhibitor vardenafil</subfield>
    <subfield code="v">13</subfield>
    <subfield code="y">2001</subfield>
    <subfield code="o">Saenz de Tejada et al, 2001</subfield>
    <subfield code="s">Int.J.Impot.Res.,13,282</subfield>
  </datafield>
  <datafield tag="FFT" ind1=" " ind2=" ">
    <subfield code="a">/afs/cern.ch/project/inspire/uploads/elsevier/consyn/consyn-files/0969-8043/S0969804316X00097/S0969804316307606/S0969804316307606.xml</subfield>
    <subfield code="t">Elsevier</subfield>
    <subfield code="o">HIDDEN</subfield>
  </datafield>
</record>